Funding

Turn ideas into impact

Viewing all 1095 opportunities
Filter Options
1095 results :
Filter List
Close
Update Filters
0
Type
Amount
Source
Eligibility
Status
View 1095 Results
Clear All Filters

Due: January 7, 2028

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

US $200,000

Type

Grant

Source

Federal

Opp Number

PAR-25-124

Due: January 7, 2028

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

US $200,000

Type

Grant

Source

Federal

Opp Number

PAR-25-273

Due: January 7, 2028

Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Type

Grant

Source

Federal

Opp Number

PAR-25-206

Due: January 7, 2028

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 – Clinical Trial Optional)

Type

Grant

Source

Federal

Opp Number

PAR-25-024

Due: January 7, 2028

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Type

Grant

Source

Federal

Opp Number

PA-25-093

Due: January 7, 2028

Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)

Type

Grant

Source

Federal

Opp Number

PAR-25-319

Due: January 7, 2028

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

Type

Grant

Source

Federal

Opp Number

PA-25-304

Due: January 7, 2028

Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)

US $200,000

Type

Grant

Source

Federal

Opp Number

PAR-25-291

Due: January 7, 2028

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Type

Grant

Source

Federal

Opp Number

PAR-25-203

Submit your funding opportunity.

Do you have a grant, incentive, funding competition, or other funding source to share?

Next up:

Facilities